PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy
Background The enzymatic conversion of arginine to citrulline is involved in gene and protein regulation and in alerting the immune system to stressed cells, including tumor cells. Nucleophosmin (NPM) is a nuclear protein that plays key roles in cellular metabolism including ribosome biogenesis, mRN...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-02-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/10/2/e003526.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850197420648955904 |
|---|---|
| author | Victoria A Brentville Rachael L Metheringham Ian Daniels Peter Symonds Katherine W Cook Mohamed Gijon Lindy G Durrant Ruhul H Choudhury Samantha J Paston |
| author_facet | Victoria A Brentville Rachael L Metheringham Ian Daniels Peter Symonds Katherine W Cook Mohamed Gijon Lindy G Durrant Ruhul H Choudhury Samantha J Paston |
| author_sort | Victoria A Brentville |
| collection | DOAJ |
| description | Background The enzymatic conversion of arginine to citrulline is involved in gene and protein regulation and in alerting the immune system to stressed cells, including tumor cells. Nucleophosmin (NPM) is a nuclear protein that plays key roles in cellular metabolism including ribosome biogenesis, mRNA processing and chromatin remodeling and is regulated by citrullination. In this study, we explored if the same citrullinated arginines within NPM are involved in gene regulation and immune activation.Methods HLA-DP4 and HLA-DR4 transgenic mice were immunized with 22 citrullinated NPM overlapping peptides and immune responses to the peptides were assessed by ex vivo ELISpot assays. Antitumor immunity of NPM targeted vaccination was assessed by challenging transgenic mice with B16F1 HHDII/iDP4, B16F1 HHDII/PAD2KOcDP4, B16F1 HHDII and Lewis lung carcinoma cells/cDP4 cells subcutaneously. Peripheral blood mononuclear cells isolated from healthy donors were stimulated with NPM266-285cit peptides with/without CD45RO+memory cell depletion to assess if the responses in human were naïve or memory.Results In contrast to NPM regulation, which is mediated by peptidylarginine deiminase (PAD4) citrullination of arginine at position 197, only citrullinated NPM266-285 peptide induced a citrulline-specific CD4 T cell response in transgenic mice models expressing human HLA-DP4 or HLA-DR4. Vaccinations with the NPM266-285cit peptide stimulated antitumor responses that resulted in dramatic tumor therapy, greatly improved survival, and protected against rechallenge without further vaccination. The antitumor response was lost if MHCII expression on the tumor cells was knocked out demonstrating direct presentation of the NPM266-285cit epitope in tumors. This antitumor response was lost in B16 tumors lacking PAD2 enzyme indicating NPM266cit is citrullinated by PAD2 in this model. Assessment of the T cell repertoire in healthy individuals and patients with lung cancer also showed CD4 T cells that respond to NPM266-285cit. The proliferative CD4 responses displayed a Th1 profile as they were accompanied with increased IFNγ and granzyme B expression. Depletion of CD45RO+ memory cells prior to stimulation suggested that responses originated from a naïve population in healthy donors.Conclusion This study indicates PAD2 can citrullinate the nuclear antigen NPM at position 277 which can be targeted by CD4 T cells for antitumor therapy. This is distinct from PAD4 citrullination of arginine 197 within NPM which results in its transport from the nucleoli to the nucleoplasm. |
| format | Article |
| id | doaj-art-2b8c7865e85b450a842ca77fb4634bb2 |
| institution | OA Journals |
| issn | 2051-1426 |
| language | English |
| publishDate | 2022-02-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj-art-2b8c7865e85b450a842ca77fb4634bb22025-08-20T02:13:10ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262022-02-0110210.1136/jitc-2021-003526PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapyVictoria A Brentville0Rachael L Metheringham1Ian Daniels2Peter Symonds3Katherine W Cook4Mohamed Gijon5Lindy G Durrant6Ruhul H Choudhury7Samantha J Paston8Scancell Ltd, Nottingham, UKScancell Ltd, Nottingham, UKScancell Ltd, Nottingham, UKScancell Ltd, Nottingham, UK1 Scancell Ltd, University of Nottingham Biodiscovery Institute, Nottingham, UKScancell Ltd, Nottingham, UKScancell Ltd, Nottingham, UKScancell Ltd, Nottingham, UKScancell Ltd, Nottingham, UKBackground The enzymatic conversion of arginine to citrulline is involved in gene and protein regulation and in alerting the immune system to stressed cells, including tumor cells. Nucleophosmin (NPM) is a nuclear protein that plays key roles in cellular metabolism including ribosome biogenesis, mRNA processing and chromatin remodeling and is regulated by citrullination. In this study, we explored if the same citrullinated arginines within NPM are involved in gene regulation and immune activation.Methods HLA-DP4 and HLA-DR4 transgenic mice were immunized with 22 citrullinated NPM overlapping peptides and immune responses to the peptides were assessed by ex vivo ELISpot assays. Antitumor immunity of NPM targeted vaccination was assessed by challenging transgenic mice with B16F1 HHDII/iDP4, B16F1 HHDII/PAD2KOcDP4, B16F1 HHDII and Lewis lung carcinoma cells/cDP4 cells subcutaneously. Peripheral blood mononuclear cells isolated from healthy donors were stimulated with NPM266-285cit peptides with/without CD45RO+memory cell depletion to assess if the responses in human were naïve or memory.Results In contrast to NPM regulation, which is mediated by peptidylarginine deiminase (PAD4) citrullination of arginine at position 197, only citrullinated NPM266-285 peptide induced a citrulline-specific CD4 T cell response in transgenic mice models expressing human HLA-DP4 or HLA-DR4. Vaccinations with the NPM266-285cit peptide stimulated antitumor responses that resulted in dramatic tumor therapy, greatly improved survival, and protected against rechallenge without further vaccination. The antitumor response was lost if MHCII expression on the tumor cells was knocked out demonstrating direct presentation of the NPM266-285cit epitope in tumors. This antitumor response was lost in B16 tumors lacking PAD2 enzyme indicating NPM266cit is citrullinated by PAD2 in this model. Assessment of the T cell repertoire in healthy individuals and patients with lung cancer also showed CD4 T cells that respond to NPM266-285cit. The proliferative CD4 responses displayed a Th1 profile as they were accompanied with increased IFNγ and granzyme B expression. Depletion of CD45RO+ memory cells prior to stimulation suggested that responses originated from a naïve population in healthy donors.Conclusion This study indicates PAD2 can citrullinate the nuclear antigen NPM at position 277 which can be targeted by CD4 T cells for antitumor therapy. This is distinct from PAD4 citrullination of arginine 197 within NPM which results in its transport from the nucleoli to the nucleoplasm.https://jitc.bmj.com/content/10/2/e003526.full |
| spellingShingle | Victoria A Brentville Rachael L Metheringham Ian Daniels Peter Symonds Katherine W Cook Mohamed Gijon Lindy G Durrant Ruhul H Choudhury Samantha J Paston PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy Journal for ImmunoTherapy of Cancer |
| title | PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy |
| title_full | PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy |
| title_fullStr | PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy |
| title_full_unstemmed | PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy |
| title_short | PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy |
| title_sort | pad 2 mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy |
| url | https://jitc.bmj.com/content/10/2/e003526.full |
| work_keys_str_mv | AT victoriaabrentville pad2mediatedcitrullinationofnucleophosminprovidesaneffectivetargetfortumorimmunotherapy AT rachaellmetheringham pad2mediatedcitrullinationofnucleophosminprovidesaneffectivetargetfortumorimmunotherapy AT iandaniels pad2mediatedcitrullinationofnucleophosminprovidesaneffectivetargetfortumorimmunotherapy AT petersymonds pad2mediatedcitrullinationofnucleophosminprovidesaneffectivetargetfortumorimmunotherapy AT katherinewcook pad2mediatedcitrullinationofnucleophosminprovidesaneffectivetargetfortumorimmunotherapy AT mohamedgijon pad2mediatedcitrullinationofnucleophosminprovidesaneffectivetargetfortumorimmunotherapy AT lindygdurrant pad2mediatedcitrullinationofnucleophosminprovidesaneffectivetargetfortumorimmunotherapy AT ruhulhchoudhury pad2mediatedcitrullinationofnucleophosminprovidesaneffectivetargetfortumorimmunotherapy AT samanthajpaston pad2mediatedcitrullinationofnucleophosminprovidesaneffectivetargetfortumorimmunotherapy |